Winnie W. Nelson - Concepedia

Author

Winnie W. Nelson

Janssen (United States)ORCID

Also Known As

Luis Jacinto, W NELSON, W Nelson, W. Nelson, W. W. Nelson, Winnie Nelson, Winnie W Nelson, Winnie W. Nelson

152

Publications

Citations

H-Index

Concepts

All Affiliations

Janssen (United States)Janssen Scientific Affairs (United States)Janssen (Belgium)Group for Research in Decision Analysis Mallinckrodt (United States)

About

Winnie W. Nelson is an author at Janssen (United States) specializing in medicine, public health, and cardiovascular disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	17	544
2	Public Health	11	11	382
3	Health Sciences	5	5	130
4	Anesthesia	4	4	101
5	Nursing	3	3	58

Winnie W. Nelson

Publications

2.8K

Citations

H-Index

Page 1

	Year	Citations
Cause of Death and Predictors of All‐Cause Mortality in Anticoagulated Patients With Nonvalvular Atrial Fibrillation: Data From ROCKET AF Sean D. Pokorney, Jonathan P. Piccini, Susanna R. Stevens, Journal of the American Heart Association	2016	196
Real-world comparative effectiveness and safety of rivaroxaban and warfarin in nonvalvular atrial fibrillation patients François Laliberté, Michel Cloutier, Winnie W. Nelson, Current Medical Research and Opinion	2014	185
Current practice patterns and patient persistence with anticoagulant treatments for cancer‐associated thrombosis Alok A. Khorana, Keith R. McCrae, Dejan Milentijevic, Research and Practice in Thrombosis and Haemostasis	2017	136
Impact of Daily Dosing Frequency on Adherence to Chronic Medications Among Nonvalvular Atrial Fibrillation Patients François Laliberté, Winnie W. Nelson, Patrick Lefèbvre, Advances in Therapy Health PolicyCardiovascular DiseaseDaily Dosing FrequencyPharmacotherapyChronic Medications	2012	122
Medication errors involving patient-controlled analgesia Rodney W. Hicks, Vanja Sikirica, Winnie W. Nelson, American Journal of Health-System Pharmacy	2008	105
Effectiveness and safety of anticoagulants for the treatment of venous thromboembolism in patients with cancer Michael B. Streiff, Dejan Milentijevic, Keith R. McCrae, American Journal of Hematology	2018	89
Effect of Increased Cost-Sharing on Oral Hypoglycemic Use in Five Managed Care Organizations Douglas W. Roblin, Richard Platt, Michael J. Goodman, Medical Care	2005	85
Impact of Once-Daily Versus Twice-Daily Dosing Frequency on Adherence to Chronic Medications among Patients with Venous Thromboembolism François Laliberté, Brahim Bookhart, Winnie W. Nelson, Patient	2013	83
Medication persistence and discontinuation of rivaroxaban versus warfarin among patients with non-valvular atrial fibrillation Winnie W. Nelson, Xue Song, Craig I Coleman, Current Medical Research and Opinion	2014	82
Burden of comorbidities among patients with atrial fibrillation Joyce LaMori, Samir H. Mody, H.J. Gross, Therapeutic Advances in Cardiovascular Disease	2012	77

Page 1